BG Medicine, Inc. (BGMD) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts BGMD Hot Sheet
Join SI Premium – FREE
BG Medicine, Inc. (NASDAQ: BGMD) reported Q3 EPS of ($0.25), $0.08 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $179 thousand versus the consensus estimate of $290 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
